Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Jul 2026 for Crestline Lending Solutions, LLC, €132k. Read the official filing
Filing timeline
BuySaleJohn Cochran
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
John Cochran: trading record in brief
John Cochran (board member) discloses dealings in 2 companies, chiefly Aquestive Therapeutics, Inc. and Crestline Lending Solutions, LLC. Between 10 May 2021 and 24 July 2026, the trades on record add up to 2 filings.
Purchases make up the whole of the open-market record (1 purchase, €132k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2026 to date brings 1 purchase and no sales.
The latest filing, published on 28 July 2026, reports an open-market purchase of €132k in Crestline Lending Solutions, LLC. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John Cochran
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
7,643.117 shares@ US$19.63100.0% of flowLimited Liability Company UnitsSEC:0001628280-26-050148:0
Canonical exit: 22 Oct 2026 (T+90)
37,500 shares0Common StockSEC:0001214659-21-006162:0
2 of 2 declarations
